Back to top
Novogen Limited (KZIA)
(Delayed Data from NSDQ)
$5.74 USD
5.74
58,805
-0.12 (-2.05%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $5.80 +0.06 (1.05%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
View All Zacks #1 Ranked StocksCash flow Statements
Fiscal Year End for Novogen Limited falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
| 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|---|
| Cash Flow From Operations, Investments & Financial Activities |
|||||
| Net Income (Loss) | NA | -13.78 | -17.88 | -6.29 | -8.37 |
| Depreciation/Amortization & Depletion | NA | 1.26 | 1.42 | 0.95 | 0.73 |
| Net Change from Assets/Liabilities | NA | 3.10 | 0.19 | -4.18 | 1.64 |
| Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Activities | NA | -0.78 | -0.24 | 2.72 | 0.09 |
| Net Cash From Operating Activities | NA | -10.20 | -16.51 | -6.81 | -5.92 |
| Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Investing Activities | NA | 0.00 | -1.72 | 0.00 | 0.00 |
| Net Cash from Investing Activities | NA | 0.00 | -1.72 | 0.00 | 0.00 |
Uses of Funds
| 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|---|
| Issuance (Repurchase) of Capital Stock | NA | 8.73 | 2.70 | 21.00 | 8.15 |
| Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash from Financing Activities | NA | 8.73 | 2.70 | 21.00 | 8.15 |
| Effect of Exchange Rate Changes | NA | 0.04 | 0.85 | -0.13 | 0.00 |
| Net Change In Cash & Equivalents | NA | -1.43 | -14.67 | 14.06 | 2.24 |
| Cash at Beginning of Period | NA | 4.96 | 20.01 | 6.55 | 3.65 |
| Cash at End of Period | NA | 3.53 | 5.34 | 20.61 | 5.89 |
| Diluted Net EPS | NA | -7.56 | -13.50 | -5.30 | -11.46 |
Fiscal Year End for Novogen Limited falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
| 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|---|
| Cash Flow From Operations, Investments & Financial Activities |
|||||
| Net Income (Loss) | NA | NA | NA | -5.75 | NA |
| Depreciation/Amortization & Depletion | NA | NA | NA | 0.61 | NA |
| Net Change from Assets/Liabilities | NA | NA | NA | 0.54 | NA |
| Net Cash from Discontinued Operations | NA | NA | NA | NA | NA |
| Other Operating Activities | NA | NA | NA | 0.47 | NA |
| Net Cash From Operating Activities | NA | NA | NA | -4.13 | NA |
| Property & Equipment | NA | NA | NA | NA | NA |
| Acquisition/ Disposition of Subsidiaries | NA | NA | NA | NA | NA |
| Investments | NA | NA | NA | NA | NA |
| Other Investing Activities | NA | NA | NA | NA | NA |
| Net Cash from Investing Activities | NA | NA | NA | NA | NA |
Uses of Funds
| 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|---|
| Issuance (Repurchase) of Capital Stock | NA | NA | NA | 2.83 | NA |
| Issuance (Repayment) of Debt | NA | NA | NA | 0.26 | NA |
| Increase (Decrease) Short-Term Debt | NA | NA | NA | NA | NA |
| Payment of Dividends & Other Distributions | NA | NA | NA | NA | NA |
| Other Financing Activities | NA | NA | NA | NA | NA |
| Net Cash from Financing Activities | NA | NA | NA | 3.10 | NA |
| Effect of Exchange Rate Changes | NA | NA | NA | -0.06 | NA |
| Net Change In Cash & Equivalents | NA | NA | NA | -1.09 | NA |
| Cash at Beginning of Period | NA | NA | NA | 3.42 | NA |
| Cash at End of Period | NA | NA | NA | 2.32 | NA |
| Diluted Net EPS | NA | NA | NA | NA | NA |